CF Pharmacotherapy Flashcards

1
Q

CF medications are given ____

A

Lifelong - adherence is VERY IMPORTANT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ideally CF patients should be…

A

Followed + managed by a multidisciplinary team specializing in CF care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The goal of pulmonary therapies is to…

A

Increase airway clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The administration order of inhaled therapies is important. This order is…

A

Bronchodilator
Hypertonic saline
Dornase Alfa
Physical airway clearance
Inhaled antibiotics
Inhaled corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pulmonary therapies are indicated in all CF patients ____ and have been shown to…

A

6+; shown to improve FEV1, QOL, and decrease rate of exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bronchodilators include…

A

SABA
SAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The purpose of bronchodilator usage is to…

A

Decrease bronchospasm associated with other inhaled therapies (hypertonic saline, antibiotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The purpose of hypertonic saline is to…

A

Increase mucous clearance from airways, by thinning out secretions - reduce viscosity + improve mucus flow

Usually start with 7% but can decrease to 3% if intolerable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Unique administration with hypertonic saline is…

A

A nebulizer machine is required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adverse effects with hypertonic saline include…

A

Coughing
Sore throat
Wheeze
Bronchospasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MOA of dornase alfa is to…

A

Decrease mucous viscosity and decrease inflammation in lungs

Good for maintain FEV1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

These are the IV antibiotics usually used for pulmonary management…

A

Levofloxacin
Aztreonam
Colistimethate
Tobramycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inhaled antibiotics are used for patients with ____ on sputum culture

A

Pseudomonas

For ealy eradication treatment, chronic suppressive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Usual regimen for IV antibiotics is ____ to help prevent resistance

A

28 days on, 28 days off - cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pancreatic enzyme replacement therapy is initiated in most patients in order to…

A

Break down fats + enhance vitamin and mineral uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

There are many types of products with various lipase units. These products…

A

Are NOT interchangeable

16
Q

Adverse effects from pancreatic enzymes include…

A

Bloating, flatulence, pain, loose stools
Steatorrhea
Dyspepsia

17
Q

These vitamins are likely the ones that will need to be replaced…

Fat-soluble !

18
Q

CFTR modulators work to…

A

Partially restore CFTR function in patients with specific mutations

SPECIFIC !!!

19
Q

CFTR modulators should be initiated…

A

At the youngest age possible

20
Q

A “corrector” in CFTR modulators works by…

A

Fixing flaws in CFTR protein, so it can form right shape + traffic to cell surface

21
Q

A “potentiator” in CFTR modulators works by…

A

Binding to defective protein at cell surface - opens chloride channel + holds it open so chloride ions can flow through

22
Q

3 drugs in Trikafta, a CFTR modulator include…

A

Elexacaftor - Corrector
Tezacaftor - Corrector
Ivacaftor - Potentiator

23
Q

Trikafta needs to be taken with…

A

Fat containing foods

24
Q

Safety concerns with Trikafta primarily include ____, hence monitoring is primarily via…

A

Elevated LFT’s
Behavioural/psychiatric changes
Cataracts

Monitoring: routine LFT monitoring, opthalmological exam

25
Q

Trikafta DI’s are usually with…

A

CYP 3A4 inhibitors and inducers

26
Q

Efficacy of Trikafta shows…

A

Significantly increased FEV1 + evidence of sustained FEV1 improvements with long-term usage
Evidence of improvement in lung function trajectory

27
Q

GERD and CF-related diabetes are treated…

A

Similarly as non-CF populations

28
Q

Azithromycin as chronic use may be considered for…

A

Patients with bacterial colonization - potential anti-inflammatory action

NOT common

29
Q

Pharmacist role in CF treatment is to…

A

Assess inhaler technique, adherence, and monitor for adverse effects/ signs of worsening disease

Assure drug coverage

30
Q

A CF exacerbation should be treated with…

Exacerbation = significant + sustained change from baseline in respiratory symptoms, pulmonary function, or chest X-ray

A

A minimum of 2 weeks IV antibiotic therapy

Pharmacist role = appropriate drug selection, therapeutic drug monitoring, etc.

31
Q

If there are NO previous cultures available to guide antimicrobial choices, empiric therapy is…

A

Piperacillin/tazobactam
Ceftazidime with IV tobramycin

Coverage for most CF pathogens and pseudomonas

32
Q

Some PK of drugs may be altered in CF. Factors that need to be considered include…

A

Extent/speed of oral absorption may be delayed
Distribution changes - malnourishment, hypoalbuminuria
Enhanced clearance of medications